|
|
 |
|
|
| (R)-2-Methyl-CBS-Oxazaborolidine,1M in toluene |
| Manus Aktteva offers Aprepitant Intermediate, 112022-83-0, (R)-2-Methyl-CBS-Oxazaborolidine, 1M in toluene, for RND for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation |
| Product Reference ID: MA-BB-496-O |
|
|
| Chemical Name: |
( R )-2-Methyl-CBS-Oxazaborolidine 1 M Solution in Toluene |
|
|
| Description |
| CAS number |
112022-83-0 |
| Synonym |
(R)-Methyl Oxazaborolidine, (R)-MeCBS, in Toluene |
| Molecular Formula |
C18H20BNO |
| Molecular Weight |
277.17 |
| Specifications |
Available on request |
| Packing |
Export worthy packing |
| Application |
Aprepitant Intermediate |
Material Safety Data Sheet
|
Available on request
|
|
|
|
|
|
 |
Other intermediates of Aprepitant offered by us are mentioned here below. For more details, you may click on the intermediate name required by you |
|
|
|
|
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|